Advanced Biomed Inc. Common Stock
ADVB | NASDAQ
$6.29
-$0.25 (-3.82%)
At close: Sep 21, 2026, 3:59 PM ET
$6.47
+$0.18 (+2.86%)
After-hours:
Sep 21, 2026, 7:30 PM ET
Fiscal Year Period Ending | FY 2025 Jun 29, 2025 | FY 2024 Jun 29, 2024 | FY 2023 Jun 29, 2023 | FY 2022 Jun 29, 2022 | FY 2021 Jun 29, 2021 |
|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 10.71K | n/a | 11.89K | n/a | n/a |
Gross Profit | -10.71K | n/a | -11.89K | n/a | n/a |
Operating Income | -94.11K | -2.54M | -99.98K | -2.37M | -1.84M |
Interest Income | 776.16 | 53.5K | 21.4K | 243 | 28 |
Pretax Income | -101.52K | -2.78M | -121.52K | -4.03M | -1.84M |
Net Income | -101.52K | -2.78M | -121.52K | -4.03M | -1.84M |
Selling & General & Admin | 55.06K | 1.26M | 43.06K | 624.77K | 44.47K |
Research & Development | 28.34K | 880.19K | 45.03K | 1.62M | 1.73M |
Other Expenses | 1 | 399.6K | 365.23K | 130.07K | 57.85K |
Operating Expenses | 83.4K | 2.54M | 88.09K | 2.37M | 1.84M |
Interest Expense | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 94.11K | 2.54M | 99.98K | 2.37M | 1.84M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 1.08M | 1.08M | 1.08M | 1.08M | 1.08M |
Shares Outstanding (Diluted) | 1.08M | 1.08M | 1.08M | 1.08M | 1.08M |
EPS (Basic) | -0.09 | -0.08 | -0.11 | -0.13 | -0.06 |
EPS (Diluted) | -0.09 | -0.08 | -0.11 | -0.13 | -0.06 |
EBITDA | -83.4K | -2.14M | -88.09K | -2.24M | -1.78M |
EBIT | -94.11K | -2.54M | -99.98K | -2.37M | -1.84M |
Depreciation & Amortization | 10.71K | 399.6K | 11.89K | 130.07K | 57.85K |
Add to Watchlist
Select watchlists to add or remove ADVB